Clinical Certificate

Anxiety Disorders

Date: Thursday 25th January 2018 – Friday 26th January 2018
Venue: The Bristol Hotel, Prince Street, Bristol, BS1 4QF
Accommodation: The Bristol Hotel, Prince Street, Bristol , BS1 4QF
(accommodation is chargeable separately when you complete the online booking form)
Organised by: David Nutt and John Potokar

Book online Pay By Invoice

Programme

Thursday 25 January
13:00–13:30 Arrival, registration and light lunch
13:30–13:35 Introduction
Dr John Potokar (Bristol)
13:35–15:00 Evidence-based pharmacological treatment of anxiety disorders
Professor David Baldwin (Southampton)
15:00–15:15 Refreshments
15:15–16:30 Two Groups
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
16:30–16:45 Refreshments and presenters swap rooms
16:45–18:00 Two Groups (repeated)
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
18:00 End of Thursday Sessions
Friday 26 January
08:45–09:15 Arrival and Coffee
09:15–10:45 The fast and the slow: exploring the duality of anxiolytic action
Professor David Nutt (London)
10:45–11:00 Refreshments
11:00–12:30 Practical therapy of anxiety: case studies
Professor David Nutt (London) and Dr David Christmas (Cambridge)
12:30–13:15 Lunch
13:15–14:30 Two Groups
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt (London) and Dr David Christmas (Cambridge)
Group B: Insomnia and other Sleep Disturbances
Dr Chris Alford (Bristol) and Dr Hugh Selsick (London)
14:30–14:45 Refreshments and presenters swap rooms
14:45–16:00 Two Groups (repeated)
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt (London) and Dr David Christmas (Cambridge)
Group B: Insomnia and other Sleep Disturbances
Dr Chris Alford (Bristol) and Dr Hugh Selsick (London)
16:00 End of meeting, return of feedback forms

Last edited 9th November 2017

Learning Objectives

At the end of one and a half day course, delegates will:

  • Be aware of current theories and the causes and neurochemistry of anxiety.
  • Know the pharmacology of both GABA and 5-HT acting anxiolytic drugs.
  • Have an understanding of the current clinical assessment of the various anxiety disorders.
  • Be aware of the merits and demerits of the various different classes of anxiolytic agents.
  • Understand the ongoing methodologies for investigating brain mechanisms of anxiety.
  • Know the clinical and pharmacology background of underpinning rational use of hypnotics.
  • Have an insight into the way alcohol acts on the brain and how these effects can be minimised.

Email: susan@bap.org.uk

This module is eligble for 10 CPD hours which are subject to peer group review.

Feedback from 2017 Module

"Thank you – another thought-provoking and interesting module"

"Very worthwhile course to attend, thank you"

"A very well run course. Very informative and relevant to be applied to current relevant practice. BAP courses are always worth attending!"

"A very good course. The time went quickly which is a sign of interesting and engaging speakers"

Print DOIs